Oscar Izeboud is the founder of Scenic Biotech. Scenic Biotech has raised $31M in total funding. Latest round: Series A. Based in Amsterdam, Netherlands.
Oscar Izeboud is the CEO of Scenic Biotech, a company focused on discovering genetic modifiers to develop therapeutics for rare genetic disorders and other illnesses. Under his leadership, Scenic Biotech closed a Series A financing round of approximately $31 million, which will be used to advance its in-house pipeline and create new programs based on its Cell-Seq genetic modifier target discovery platform. The company is progressing a lead immuno-oncology program towards clinical trials and multiple rare disease programs towards IND enabling studies.
Full founder directory · Investor directory · Company funding database · Fundraising library